DJIA 17,086.63 -26.91 -0.16%
NASDAQ 4,473.70 17.68 0.40%
S&P 500 1,987.01 3.48 0.18%
market minute promo

Dendreon Corp (NASDAQ: DNDN)

2.17 0.07 (3.33%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

DNDN $2.17 3.33%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.10
Previous Close $2.10
Daily Range $2.10 - $2.17
52-Week Range $1.81 - $5.38
Market Cap $347.1M
P/E Ratio -1.23
Dividend (Yield) $0.00 (0.0%)
Volume 1,535,330
Average Daily Volume 2,048,761
Current FY EPS -$0.77





Dendreon Corp (DNDN) Description

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. Website:

News & Commentary

These 5 Cancer Immunotherapy Companies All Have 1 Thing in Common

Cancer immunotherapies are all the rage on Wall Street, but these five immunotherapy-focused companies all have one big thing in common.

Why You Should Buy Dendreon's Drop

August 29th Options Now Available For Dendreon

Stocks To Watch Today: NQ Mobile, CBS, Seadrill...

Morning Market Movers

Benzinga's Top #PreMarket Gainers

New Provenge Data: Why Deerfield Investments Acquired A More Than 5% Stake In May

What Does Dendreon Need To Succeed?

Dendreon (DNDN) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape

Long Or Short: Cancer Cures

Dendreon May Still Be In Play

See More DNDN News...

DNDN's Top Competitors

DNDN $2.17 (3.33%)
Current stock: DNDN
GILD $90.34 (1.13%)
Current stock: GILD
CELG $89.12 (2.84%)
Current stock: CELG
BIIB $337.60 (11.17%)
Current stock: BIIB